Cargando…

Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain

Chronic pain is an enormous modern public health problem, with significant numbers of people debilitated by chronic pain from a variety of etiologies. Translocator protein 18 kDa (TSPO) was discovered in 1977 as a peripheral benzodiazepine receptor. It is a five transmembrane domain protein, mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Huang, Jingyao, Zhang, Zhenjiang, Zhang, Rui, Zhang, Zhihao, Liu, Yongxin, Ma, Baoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444456/
https://www.ncbi.nlm.nih.gov/pubmed/36071748
http://dx.doi.org/10.1155/2022/8057854
_version_ 1784783222611116032
author Liu, Jie
Huang, Jingyao
Zhang, Zhenjiang
Zhang, Rui
Zhang, Zhihao
Liu, Yongxin
Ma, Baoyu
author_facet Liu, Jie
Huang, Jingyao
Zhang, Zhenjiang
Zhang, Rui
Zhang, Zhihao
Liu, Yongxin
Ma, Baoyu
author_sort Liu, Jie
collection PubMed
description Chronic pain is an enormous modern public health problem, with significant numbers of people debilitated by chronic pain from a variety of etiologies. Translocator protein 18 kDa (TSPO) was discovered in 1977 as a peripheral benzodiazepine receptor. It is a five transmembrane domain protein, mainly localized in the outer mitochondrial membrane. Recent and increasing studies have found changes in TSPO and its ligands in various chronic pain models. Reversing their expressions has been shown to alleviate chronic pain in these models, illustrating the effects of TSPO and its ligands. Herein, we review recent evidence and the mechanisms of TSPO in the development of chronic pain associated with peripheral nerve injury, spinal cord injury, cancer, and inflammatory responses. The cumulative evidence indicates that TSPO-based therapy may become an alternative strategy for treating chronic pain.
format Online
Article
Text
id pubmed-9444456
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94444562022-09-06 Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain Liu, Jie Huang, Jingyao Zhang, Zhenjiang Zhang, Rui Zhang, Zhihao Liu, Yongxin Ma, Baoyu Neural Plast Review Article Chronic pain is an enormous modern public health problem, with significant numbers of people debilitated by chronic pain from a variety of etiologies. Translocator protein 18 kDa (TSPO) was discovered in 1977 as a peripheral benzodiazepine receptor. It is a five transmembrane domain protein, mainly localized in the outer mitochondrial membrane. Recent and increasing studies have found changes in TSPO and its ligands in various chronic pain models. Reversing their expressions has been shown to alleviate chronic pain in these models, illustrating the effects of TSPO and its ligands. Herein, we review recent evidence and the mechanisms of TSPO in the development of chronic pain associated with peripheral nerve injury, spinal cord injury, cancer, and inflammatory responses. The cumulative evidence indicates that TSPO-based therapy may become an alternative strategy for treating chronic pain. Hindawi 2022-08-29 /pmc/articles/PMC9444456/ /pubmed/36071748 http://dx.doi.org/10.1155/2022/8057854 Text en Copyright © 2022 Jie Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Liu, Jie
Huang, Jingyao
Zhang, Zhenjiang
Zhang, Rui
Zhang, Zhihao
Liu, Yongxin
Ma, Baoyu
Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title_full Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title_fullStr Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title_full_unstemmed Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title_short Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain
title_sort translocator protein 18 kda (tspo) as a novel therapeutic target for chronic pain
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444456/
https://www.ncbi.nlm.nih.gov/pubmed/36071748
http://dx.doi.org/10.1155/2022/8057854
work_keys_str_mv AT liujie translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT huangjingyao translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT zhangzhenjiang translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT zhangrui translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT zhangzhihao translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT liuyongxin translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain
AT mabaoyu translocatorprotein18kdatspoasanoveltherapeutictargetforchronicpain